Anteris Bio

Life Sciences
Written By Guest User
 

Anteris Bio is a portfolio company focused on developing HPP971 as a new therapy for the treatment of renal disease.

  • Chief Medical Officer

Guest User
Previous

Ambys Medicines
Next

Astex Pharmaceuticals